Tencent co-led a series E1 round for the cancer drug development services provider, which counts China Electronics Corporation and Ping An as earlier investors.
China-based oncology services provider Medbanks has received RMB2bn ($305m) in a series E1 round co-led by internet group Tencent and technology investment firm Jeneration Capital, DealStreetAsia reported yesterday.
Venture capital firm 5Y Capital, fund manager Forebright Capital, family office Wu Capital and an unnamed insurance private equity fund also participated in the round, according to a statement by Taihecap, the financial adviser on the transaction.
Medbanks helps drug developers and healthcare providers coordinate efforts on new drug applications and clinical…
